Durham's Heat Bio takes critical step in testing experimental drug in lung cancer patients
September 18, 2014 at 11:17 AM EDT
Durham drug developer Heat Biologics, Inc. began dosing a Phase 2 trial to test an experimental drug in lung cancer patients...
